--- title: FELDAN THERAPEUTICS CHAIRMAN REFLECTS ON KEY ACHIEVEMENTS AT ANNUAL SHAREHOLDERS MEETING description: Feldan Therapeutics Chairman David J. Mazzo Reflects on Key Achievements at Annual Shareholders Meeting --- [![Feldan therapeutics](https://www.feldan.com/hs-fs/hubfs/FELDAN-lg-couleur.png?width=2379&height=1537&name=FELDAN-lg-couleur.png "Feldan therapeutics")](https://www.feldan.com/?hsLang=en) [![Contact us](https://no-cache.hubspot.com/cta/default/6481368/a79f9fa2-131e-425f-8bcb-bc74a0bd68c6.png)](https://cta-redirect.hubspot.com/cta/redirect/6481368/a79f9fa2-131e-425f-8bcb-bc74a0bd68c6) ** [** ](https://www.linkedin.com/company/feldantherapeutics/) [** ](https://www.facebook.com/feldantherapeutics) ** ** [![FELDAN-lg-couleur250](https://www.feldan.com/hs-fs/hubfs/FELDAN-lg-couleur250.png?width=200&height=81&name=FELDAN-lg-couleur250.png "FELDAN-lg-couleur250")](https://www.feldan.com/?hsLang=en) [![Contact us](https://no-cache.hubspot.com/cta/default/6481368/a79f9fa2-131e-425f-8bcb-bc74a0bd68c6.png)](https://cta-redirect.hubspot.com/cta/redirect/6481368/a79f9fa2-131e-425f-8bcb-bc74a0bd68c6) ** [** ](https://www.linkedin.com/company/feldantherapeutics/) [** ](https://www.facebook.com/feldantherapeutics) ** ** Search **Menu** ** ** [![Contact us](https://no-cache.hubspot.com/cta/default/6481368/a79f9fa2-131e-425f-8bcb-bc74a0bd68c6.png)](https://cta-redirect.hubspot.com/cta/redirect/6481368/a79f9fa2-131e-425f-8bcb-bc74a0bd68c6) # FELDAN THERAPEUTICS CHAIRMAN REFLECTS ON KEY ACHIEVEMENTS AT ANNUAL SHAREHOLDERS MEETING by [Feldan](https://www.feldan.com/news/author/feldan) on Mar 31,2026 During the Annual Shareholders Meeting of Feldan Therapeutics, held in March 2026, Chairman of the Board Dr. David J. Mazzo addressed the company’s achievements over the past year and outlined strategic priorities moving forward. "*Good afternoon, Ladies and Gentlemen,* *My name is David Mazzo and I am the Chairman of the Board of Feldan Therapeutics. Along with my fellow board directors and the management team, I welcome you to our annual shareholders meeting. The last year has been a productive and even transformative year for our company, full of many accomplishments. As our CEO, Francois-Thomas, will shortly tell you, we have made great advances in our clinical and preclinical programs, increasing the interest in and value of our shuttle platform technology. Notably, François-Thomas and the team have done a tremendous job attracting new investors and sourcing new capital, including non-dilutive capital, into the company. The last several years have been a challenging time for small healthcare company financing and the fact that Feldan continues to have access to the funds needed to move our projects to their next development milestone speaks to the potential that others see in what we are doing. The management team and the board remain mindful of the trust that shareholders have endowed when they have invested. Our efforts are focused on achieving increasing shareholder value while advancing promising new drugs through development in the most cost-efficient way possible. Thank you for your continued support. From where we sit, the future looks bright indeed.*" Reflecting on the chairman’s remarks, Feldan is confident in the strength of its team, its strategic direction, and the progress of its clinical and preclinical programs. Looking ahead, the Company remains focused on leveraging its unique technology to deliver innovative therapies while driving sustainable growth and long-term success. - [Recent](https://www.feldan.com/news/feldan-therapeutics-chairman-reflects-on-key-achievements-at-annual-shareholders-meeting#recent) - [Archive](https://www.feldan.com/news/feldan-therapeutics-chairman-reflects-on-key-achievements-at-annual-shareholders-meeting#archive) - [January 2018 (2)](https://www.feldan.com/news/archive/2018/01) - [March 2018 (2)](https://www.feldan.com/news/archive/2018/03) - [April 2018 (2)](https://www.feldan.com/news/archive/2018/04) - [May 2018 (2)](https://www.feldan.com/news/archive/2018/05) - [June 2018 (2)](https://www.feldan.com/news/archive/2018/06) - [November 2018 (2)](https://www.feldan.com/news/archive/2018/11) - [June 2019 (2)](https://www.feldan.com/news/archive/2019/06) - [April 2021 (2)](https://www.feldan.com/news/archive/2021/04) - [June 2023 (2)](https://www.feldan.com/news/archive/2023/06) - [February 2024 (2)](https://www.feldan.com/news/archive/2024/02) - [March 2026 (2)](https://www.feldan.com/news/archive/2026/03) - [September 2016 (1)](https://www.feldan.com/news/archive/2016/09) - [April 2017 (1)](https://www.feldan.com/news/archive/2017/04) - [August 2017 (1)](https://www.feldan.com/news/archive/2017/08) - [September 2018 (1)](https://www.feldan.com/news/archive/2018/09) - [October 2018 (1)](https://www.feldan.com/news/archive/2018/10) - [December 2018 (1)](https://www.feldan.com/news/archive/2018/12) - [February 2019 (1)](https://www.feldan.com/news/archive/2019/02) - [October 2019 (1)](https://www.feldan.com/news/archive/2019/10) - [June 2020 (1)](https://www.feldan.com/news/archive/2020/06) - [January 2021 (1)](https://www.feldan.com/news/archive/2021/01) - [February 2021 (1)](https://www.feldan.com/news/archive/2021/02) - [January 2022 (1)](https://www.feldan.com/news/archive/2022/01) - [March 2023 (1)](https://www.feldan.com/news/archive/2023/03) - [April 2023 (1)](https://www.feldan.com/news/archive/2023/04) - [August 2023 (1)](https://www.feldan.com/news/archive/2023/08) - [September 2023 (1)](https://www.feldan.com/news/archive/2023/09) - [October 2023 (1)](https://www.feldan.com/news/archive/2023/10) - [December 2023 (1)](https://www.feldan.com/news/archive/2023/12) - [September 2024 (1)](https://www.feldan.com/news/archive/2024/09) - [October 2024 (1)](https://www.feldan.com/news/archive/2024/10) - [January 2025 (1)](https://www.feldan.com/news/archive/2025/01) - [February 2025 (1)](https://www.feldan.com/news/archive/2025/02) - [April 2025 (1)](https://www.feldan.com/news/archive/2025/04) - [June 2025 (1)](https://www.feldan.com/news/archive/2025/06) - [September 2025 (1)](https://www.feldan.com/news/archive/2025/09) - [January 2026 (1)](https://www.feldan.com/news/archive/2026/01) [More...](https://www.feldan.com/news/feldan-therapeutics-chairman-reflects-on-key-achievements-at-annual-shareholders-meeting#) ![FELDAN-lg-blanc-1](https://www.feldan.com/hs-fs/hubfs/FELDAN-lg-blanc-1.png?width=296&name=FELDAN-lg-blanc-1.png) ## Address 2666, Boul. du Parc Technologique, Suite 290 Quebec, Qc, Canada, G1P 4S6 Phone: [1-418-872-7277](tel:1-418-872-7277) Email: [info@feldan.com](mailto:info@feldan.com) [** ](https://www.linkedin.com/company/feldantherapeutics/) [** ](https://www.facebook.com/feldantherapeutics) Copyright © Feldan Therapeutics, 2024. All Rights Reserved.